← Leaderboards
Philip A Osdoby
Barnes-Jewish Hospital
$2,596,136
Attributed
$2,596,136
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $196.1K · FY2007–08$200K$150K$100K$50K$0
'07
'08
Funding mix
By agency
NIH$2,596,136 · 5
By mechanism
R01$1,994,084 · 3
R21$356,212 · 1
P01$245,840 · 1
Top collaborators
No co-investigators on record.
Most similar at Barnes-Jewish Hospital
Same institution · by research overlap
- Keith A Hruska$12,070,993
- Roberto Civitelli$15,701,535
- Steven R Mumm$2,917,246
- F. Patrick Ross$4,287,010
- Leonard Rifas$388,840
Others in their field
Top investigators on “Osteoclasts”
- Brendan Hl Lee · Baylor College Of Medicine$18,789,257
- Steven L Teitelbaum · Washington University$16,498,459
- Mone Zaidi · Icahn School Of Medicine At Mount Sinai$16,089,949
- Karl Leonard Insogna · Yale University$15,344,415
- Yi-Ping Li · Tulane University Of Louisiana$14,733,549
- Yongwon Choi · University Of Pennsylvania$14,421,139
Research focus
OsteoclastsChickensLaboratory MouseIn Situ HybridizationCell DifferentiationRnase Protection AssayPolymerase Chain ReactionPathologic Bone ResorptionNitric OxideInterleukin 1Northern BlottingsGlucocorticoidsOsteogenesisBone Metabolism DisorderHuman TissueImmunocytochemistryNucleic Acid SequenceCell Cell InteractionCd14 MoleculeBiological Signal TransductionGel Mobility Shift AssayNitric Oxide SynthaseCytokine ReceptorsConfocal Scanning Microscopy
Grant awards (13)
OSTEOGENESIS IMPERFECTA, AND NITRIC OXIDE THERAPY$160,132
R21 · FY2008 · AR · contact PI
OSTEOGENESIS IMPERFECTA, AND NITRIC OXIDE THERAPY$196,080
R21 · FY2007 · AR · contact PI
NITRIC OXIDE, OSTEOCLASTS AND METABOLIC BONE DISEASE$217,140
R01 · FY2004 · AR
NITRIC OXIDE, OSTEOCLASTS AND METABOLIC BONE DISEASE$217,140
R01 · FY2003 · AR
CELLULAR BASIS OF CRANIOFACIAL BONE DISORDERS$223,646
R01 · FY2002 · DE
NITRIC OXIDE, OSTEOCLASTS AND METABOLIC BONE DISEASE$217,140
R01 · FY2002 · AR
NITRIC OXIDE, OSTEOCLASTS AND METABOLIC BONE DISEASE$217,140
R01 · FY2001 · AR
CELLULAR BASIS OF CRANIOFACIAL BONE DISORDERS$217,132
R01 · FY2001 · DE
OSTEOCLAST MEDIATED BONE REMODELING$0
P01 · FY2001 · AR
CELL SURFACE AND OSTEOCLAST DEVELOPMENT$256,269
R01 · FY2000 · AG
OSTEOCLAST MEDIATED BONE REMODELING$245,840
P01 · FY2000 · AR
NITRIC OXIDE, OSTEOCLASTS AND METABOLIC BONE DISEASE$217,669
R01 · FY2000 · AR
CELLULAR BASIS OF CRANIOFACIAL BONE DISORDERS$210,808
R01 · FY2000 · DE